
Seattle Children’s Research Institute
1920 Terry Ave.
Seattle, WA
Scientific Symposium
(Lunch Provided)
9 am – 5 pm
Poster Session & Reception
(Appetizers & Wine)
5 – 7 pm
Explore the full lineup of panels and presentations below and be part of the conversation shaping the future of rare disease research. Each session highlights groundbreaking work that is transforming our understanding of rare diseases.
DOORS OPEN
8:45 am
15 minutes
Coffee & Pastries
WELCOME
9:00 am
5 minutes
Welcome to Rare Genetic Disease Research in Seattle and Beyond

Cláudia Carvalho, PhD
Assistant Investigator, Pacific Northwest Research Institute
Panel
1
9:05am
45 minutes
A Conversation With Rare Disease Advocates: Strengthening Collaboration Among Clinicians, Researchers, and Those With Lived Experience

Moderator: Kimberly Aldinger, PhD
Principal Investigator, Norcliffe Center for Integrative Brain Research, Seattle Children’s Research Institute, and Assistant Professor, Department of Pediatrics, University of Washington

Carolina Sommer
Founder & CEO, Born a Hero, and Co-founder, NW Rare Disease Coalition

Erin Tansey
Patient & Family Experience Specialist, Seattle Children’s

Maddie Gillentine, PhD
Research Director, HNRNP Family Foundation

Nora Xu
Director, Foundation for Angelman Syndrome Therapeutics
SESSION
1
9:50am
60 minutes
featuring clinician voices
The Clinical Perspective

Precision Medicine for Vascular Anomalies: The Tissue’s the Issue
Moderator: James T. Bennett, MD, PhD
Associate Professor, Center for Developmental Biology and Regenerative Medicine, Seattle Children’s Research Institute, Dept. of Pediatrics, Division Genetic Medicine, Adjunct in Dept. of Lab Medicine and Pathology, University of Washington

Targeted Therapies for Genetic Conditions
Margaret L.P. Adam, MD
Attending Physician, Seattle Children’s Hospital, Editor-in-Chief, GeneReviews, and Professor, Dept. of Pediatrics, Division of Genetic Medicine, University of Washington School of Medicine

Building an International Collaboration for the Identification of and Care for Patients with Rare Genetic Conditions in Vietnam
Kathleen A. Leppig, MD
Acting Director, Division of Medical Genetics, Fred Hutch, and Clinical Professor, Division of Medical Genetics, University of Washington School of Medicine

Implementation of First-Line Rapid Genome Sequencing for Pediatric Inpatients
Alexandra C. Keefe, MD, PhD
Clinical Genetics, Seattle Children’s Hospital

One Among Many: Lessons Learned From Joubert Syndrome
Dan Doherty, MD, PhD
Professor, University of Washington Pediatrics, Interim Head, Division of Developmental Medicine, Director, Hindbrain Malformation Research Program, and Affiliate Member, Center for Integrative Brain Research
BREAK
10:50 am
25 minutes
Networking Break
SESSION
2
11:15am
60 minutes
Large Scale Studies and Resources for Rare Disease Research

University of Washington Center for Rare Disease Research: Gene Discovery and Methods to Discover the Causes of Rare Diseases
Moderator: Jessica X. Chong, PhD
Associate Professor, University of Washington

Undiagnosed Diseases Network: Finding Answers for Families with Rare Diseases
Katrina M. Dipple, MD, PhD
Professor, University of Washington, Department of Pediatrics, Division of Genetic Medicine, and Medical Director, Genetic Medicine, Seattle Children’s Hospital

Pros and Cons of Applying Large Data Sets to Patients Diagnosed With Rare and Ultra-Rare Genetic Disorders
Ian A. Glass, MBChB, MD, FACMG
Medical Genetics, Seattle Children’s Hospital, Professor of Pediatrics and Medicine, University of Washington School of Medicine

Leveraging Databases for Clinical Variant Classification
Cate Paschal, PhD, FACMG
Director, Cytogenetics and Molecular Diagnostics, Seattle Children’s Hospital
LUNCH
12:15 pm
60 minutes
Catered Networking Lunch and Poster Session #1
SESSION
3
1:15pm
60 minutes
Models to Study DNA Variants in Rare Diseases

Yeast Functional Assays for Genetic Variant Interpretation
Moderator: Aimée Dudley, PhD
Senior Investigator & Interim Chief Scientific Officer, Pacific Northwest Research Institute

Understanding Non-Coding Contributions to Retinal Disease With Molecular and Machine Modeling
Timothy Cherry, PhD
Principal Investigator, Seattle Children’s Research Institute’s Center for Developmental Biology and Regenerative Medicine, Associate Professor, University of Washington School of Medicine’s Dept. of Pediatrics and Division of Genetic Medicine

Zebrafish Models of Congenital Muscle Disorders: Genetics, Etiology, and Drug Screening
Lisa Maves, PhD
Principal Investigator, Seattle Children’s Research Institute, and Associate Professor, Pediatrics, University of Washington School of Medicine

Using 3D-Engineered Cardiac and Skeletal Muscle Tissues for DMD Disease Modeling and Drug Discovery
David Mack, PhD
Associate Professor, Dept. of Rehabilitation Medicine and Bioengineering and the Dept. of Neurobiology and Biophysics, and Investigator, Institute for Stem Cell and Regenerative Medicine, University of Washington
SESSION
4
2:15 pm
60 minutes
Implementing New Omics Technologies to Investigate Rare Diseases

Long-Read Sequence Assembly and Disease Susceptibility
Moderator: Evan Eichler, PhD
HHMI Investigator and Professor, Department of Genome Sciences, University of Washington

Uncovering Hidden Pathogenic Structural Variants in Rare Diseases
Cláudia M.B. Carvalho, PhD
Assistant Investigator, Pacific Northwest Research Institute

The Promise of Long-Read Genome Sequencing in the Clinical and Research Setting
Danny E. Miller, MD, PhD, FACMG
Principal Investigator, Seattle Children’s Research Institute, and Associate Professor, Pediatrics, University of Washington School of Medicine

Synchronous Long-Read Multi-Ome Sequencing for Resolving Rare Diseases
Andrew B. Stergachis, MD, PhD
Associate Professor, Medical Genetics and Genome Sciences, University of Washington

Deciphering the Genetic Configurations of Rare Diseases Through the Multiomic Approaches
Chia-Lin Wei, PhD
Professor, Director, Northwest Genomics Center (NWGC), Department of Genome Sciences, University of Washington
BREAK
3:15 pm
25 minutes
Networking Break
SESSION
5
3:40 pm
60 minutes
Clinical Trials and Therapeutic Development

Urea Cycle Disorders: From Nitrogen Scavengers to Gene Therapy – A Journey to Break the Cycle
Moderator: Andrea Gropman, MD, FAAP, FACMG, FANA, FCNS
Mark Tamer Endowed Chair in Pediatric Neurology, Director, Neurometabolic Translational Research Unit, Center for Experimental Therapeutics, St. Jude Children’s Research Hospital

Lessons Learned From Clinical Trials in Congenital Disorders of Glycosylation
Christina Lam, MD
Medical Director, Biochemical Genetics, Seattle Children’s Hospital, and Associate Professor, Dept. of Pediatrics, University of Washington School of Medicine

Genomic Studies in MECP2 Duplication Syndrome Provides Guidance for Individualized Treatment
Davut Pehlivan, MD
Assistant Professor, Baylor College of Medicine
CLOSING REMARKS
4:40 pm
20 minutes
Closing Remarks

Vittorio Gallo, PhD
Senior Vice President and Chief Scientific Officer, Seattle Children’s Research Institute

Jack Faris, PhD
Chief Executive Officer, Pacific Northwest Research Institute
RECEPTION
5:00 pm
2 hours